Ionis Pharmaceuticals plunges 20% after its clinical trial partner Roche discontinues dosing in Phase 3 trial of tominersen Check out this evening's top movers from around Wall Street, compiled by The Fly.
UP AFTER EARNINGS
- Biolife Solutions (BLFS) up 16.7%
- Guild Holdings (GHLD) up 2.1%
ALSO HIGHER
- Eastman Kodak (KODK) up 3.6% after getting commitment from ONLINEPRINTERS Group
DOWN AFTER EARNINGS
- Viant Technology (DSP) down 9.8%
- Raven Industries (RAVN) down 8.5%
ALSO LOWER
- Ionis Pharma (IONS) down 19.5% after announcing that its study partner Roche will discontinue dosing in Phase 3 GENERATION HD1 trial of tominersen in manifest Huntington's disease
- Exagen (XGN) down 8.5% after equity offering
- QuantumScope (QS) down 7.9% after equity offering
- Piedmont Lithium (PLL) down 6.2% after equity offering
- MP Materials (MP) down 5.5% after equity offering
- Western Midstream (WES) down 3.0% after offering stock for holders
- Verrica Pharma (VRCA) down 2.6% after equity offering
Symbols:
BLFS GHLD KODK DSP RAVN IONS XGN QS PLL MP WES VRCA Keywords: fly intel, wall street, afterhours, movers, top stories, stocks, Ionis Pharma